Zobrazeno 1 - 10
of 199
pro vyhledávání: '"François Nosten"'
Autor:
Jade D. Rae, Jordi Landier, Angela Devine, Stephane Proux, François Nosten, Richard J. Maude, Saw Win Tun, Aung Myint Thu, May Myo Thwin, Ladda Kajeechiwa, Jacher Wiladphaingern, Julie A. Simpson
Publikováno v:
BMC Public Health, Vol 21, Iss 1, Pp 1-12 (2021)
BMC Public Health
BMC Public Health, 2021, 21 (1), pp.1725. ⟨10.1186/s12889-021-11749-x⟩
BMC Public Health, BioMed Central, 2021, 21 (1), pp.1725. ⟨10.1186/s12889-021-11749-x⟩
BMC Public Health
BMC Public Health, 2021, 21 (1), pp.1725. ⟨10.1186/s12889-021-11749-x⟩
BMC Public Health, BioMed Central, 2021, 21 (1), pp.1725. ⟨10.1186/s12889-021-11749-x⟩
Background Providing at-risk communities with uninterrupted access to early diagnosis and treatment is a key component in reducing malaria transmission and achieving elimination. As programmes approach malaria elimination targets it is critical that
Autor:
Ricardo Aguas, Lisa J. White, François Nosten, Shwe Sin Kyaw, Wirichada Pan-Ngum, Olivier Celhay, Sasithon Pukrittayakamee, Yoel Lubell, Gilles Delmas, Richard J. Maude, Tom Drake
Publikováno v:
BMC Public Health, Vol 21, Iss 1, Pp 1-12 (2021)
BMC Public Health
BMC Public Health
Background Mass drug administration (MDA) has received growing interest to accelerate the elimination of multi-drug resistant malaria in the Greater Mekong Subregion. Targeted MDA, sometimes referred to as focal MDA, is the practice of delivering MDA
Autor:
Mallika Imwong, Arjen M. Dondorp, François Nosten, Usa Boonyuen, Frank Smithuis, Naowarat Saralamba, Nicholas P. J. Day, Yupawadee Pimpat, Sasithon Pukrittayakamee
Publikováno v:
Malaria Journal, Vol 19, Iss 1, Pp 1-13 (2020)
Malaria Journal
Malaria journal, 19(1):315. BioMed Central
Malaria Journal
Malaria journal, 19(1):315. BioMed Central
Background Plasmodium malariae is a widely spread but neglected human malaria parasite, which causes chronic infections. Studies on genetic polymorphisms of anti-malarial drug target genes in P. malariae are limited. Previous reports have shown polym
Autor:
Blaise Genton, Michael Nambozi, Elizabeth A. Ashley, Anupkumar R. Anvikar, François Nosten, Norah Mwebaza, Neena Valecha, Khin Maung Lwin, Aung Pyae Phyo, Myaing M. Nyunt, Steven R. Meshnick, Jean-Louis A Ndiaye, Kanlaya Sriprawat, Nicholas J. White, Irene Kuepfer, Harry Tagbor, Rose McGready, Marcus J. Rijken, Patrice Piola, Rashid Mansoor, Dominic Mosha, Halidou Tinto, Moo Kho Paw, Linda Kalilani-Phiri, Victor Mwapasa, Umberto D'Alessandro, Mary Ellen Gilder, Innocent Valea, Jacher Wiladphaingern, Miriam K. Laufer, Makoto Saito, Elizabeth Juma, Philippe J Guerin, Bernhards Ogutu, Sunil Parikh, Kasia Stepniewska, Lauren M. Cohee, Daniel Chandramohan, Mupawjay Pimanpanarak, Kalynn Kennon, Joel Tarning
Publikováno v:
The Lancet. Infectious diseases, vol. 20, no. 8, pp. 943-952
Lancet infectious diseases, 20(8), 943-952. Lancet Publishing Group
The Lancet. Infectious Diseases
Lancet infectious diseases, 20(8), 943-952. Lancet Publishing Group
The Lancet. Infectious Diseases
Background: Malaria in pregnancy affects both the mother and the fetus. However, evidence supporting treatment guidelines for uncomplicated (including asymptomatic) falciparum malaria in pregnant women is scarce and assessed in varied ways. We did a
Autor:
Chris Drakeley, Julia Mwesigwa, Umberto D'Alessandro, Antonio M. Quispe, Kimberly M. Fornace, Joanna Gallay, Michelle A. Chang, Jacklin F. Mosha, Siv Sovannaroth, Jordi Landier, Fitsum G. Tadesse, Nuno Sepúlveda, André Siqueira, Gilles Delmas, François Nosten, Ewan Cameron, Teun Bousema, Fe Espino, Daniel J. Bridges, Jennifer C. Stevenson, Koukeo Phommasone, Emilie Pothin, John M. Miller, Karen E. S. Hamre, Alyssa J. Young, Mayfong Mayxay, Marcus V. G. Lacerda, Shunmay Yeung, Lynn Grignard, Arjen M. Dondorp, Thomas P. Eisele, Peter W. Gething, Gillian Stresman, Pauline Joy Lorenzo, Daniel M. Parker, Katherine E. Battle, Jean Frantz Lemoine, Maria Lourdes M. Macalinao, Lorenz von Seidlein, Jane Achan
Publikováno v:
The Lancet. Infectious Diseases
The Lancet Infectious Diseases
The Lancet Infectious Diseases, New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-, 2020, 20 (8), pp.953-963. ⟨10.1016/S1473-3099(20)30059-1⟩
Lancet infectious diseases, 20(8), 953-963. Lancet Publishing Group
The Lancet Infectious Diseases, 2020, 20 (8), pp.953-963. ⟨10.1016/S1473-3099(20)30059-1⟩
Lancet Infectious Diseases, 20, 953-963
Lancet Infectious Diseases, 20, 8, pp. 953-963
The lancet infectious diseases
The Lancet. Infectious diseases, vol 20, iss 8
The Lancet Infectious Diseases
The Lancet Infectious Diseases, New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-, 2020, 20 (8), pp.953-963. ⟨10.1016/S1473-3099(20)30059-1⟩
Lancet infectious diseases, 20(8), 953-963. Lancet Publishing Group
The Lancet Infectious Diseases, 2020, 20 (8), pp.953-963. ⟨10.1016/S1473-3099(20)30059-1⟩
Lancet Infectious Diseases, 20, 953-963
Lancet Infectious Diseases, 20, 8, pp. 953-963
The lancet infectious diseases
The Lancet. Infectious diseases, vol 20, iss 8
Background: \ud Passively collected malaria case data are the foundation for public health decision making. However, because of population-level immunity, infections might not always be sufficiently symptomatic to prompt individuals to seek care. Und
Autor:
Jureeporn Duanguppama, James A Watson, Nicholas J. White, Caroline O. Buckee, Nicholas P. J. Day, François Nosten, Daniel E. Neafsey, Cindy S. Chu, Mallika Imwong, Aimee R. Taylor, Kanokpich Puaprasert
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-11 (2019)
Nature Communications
Nature Communications
Relapses arising from dormant liver-stage Plasmodium vivax parasites (hypnozoites) are a major cause of vivax malaria. However, in endemic areas, a recurrent blood-stage infection following treatment can be hypnozoite-derived (relapse), a blood-stage
Autor:
Kanokpich Puaprasert, Htun Htun Win, François Nosten, Suradet Thinraow, Widi Yotyingaphiram, Pornpimon Wilaisrisak, Joel Tarning, Aye Aye Aung, Mallika Imwong, James A Watson, Cindy S. Chu, Daniel Blessborn, Stephane Proux, Nicholas J. White, Aung Pyae Phyo, Nay Lin Soe, Clare L. Ling, Warunee Hanpithakpong
Publikováno v:
Antimicrobial agents and chemotherapy
BackgroundPrimaquine is the only widely available drug for radical cure of Plasmodium vivax malaria. There is uncertainty whether the pharmacokinetic properties of primaquine are altered significantly in childhood or not.MethodsGlucose-6-phosphate de
Autor:
Jordi Landier, Thomas J. Peto, Frank Smithuis, Mavuto Mukaka, Mark Debackere, Walter R. J. Taylor, Lorenz von Seidlein, Arnaud Tarantola, Tran Tinh Hien, Arjen M. Dondorp, Rupam Tripura, Arantxa Roca-Feltrer, Koukeo Phommasone, Pimnara Peerawaranun, Sim Kheng, François Nosten, Nicholas J. White, Philippe Buchy, Joel Tarning, Sinoun Muth, Lek Dysoley, Soy Ty Kheang, Thuy Nguyen, Didier Menard, Ngak Song, Chy Say, Leang Rithea, Mayfong Mayxay, Kak Neeraj, Rick M. Fairhurst, Richard M. Hoglund
Publikováno v:
Malaria journal, 20(1):366. BioMed Central
Malaria Journal
Malaria Journal, 2021, 20 (1), pp.366. ⟨10.1186/s12936-021-03886-w⟩
Malaria Journal, Vol 20, Iss 1, Pp 1-10 (2021)
Malaria Journal, BioMed Central, 2021, 20 (1), pp.366. ⟨10.1186/s12936-021-03886-w⟩
Malaria Journal
Malaria Journal, 2021, 20 (1), pp.366. ⟨10.1186/s12936-021-03886-w⟩
Malaria Journal, Vol 20, Iss 1, Pp 1-10 (2021)
Malaria Journal, BioMed Central, 2021, 20 (1), pp.366. ⟨10.1186/s12936-021-03886-w⟩
Background In many endemic areas, Plasmodium vivax malaria is predominantly a disease of young adults and children. International recommendations for radical cure recommend fixed target doses of 0.25 or 0.5 mg/kg/day of primaquine for 14 days in gluc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e290e5a1b236134f2743a06296dc950
https://doi.org/10.1186/s12936-021-03886-w
https://doi.org/10.1186/s12936-021-03886-w
Autor:
Jianqing Lin, Bruce Russell, Trang T. T. Chu, Alice Soh Meoy Ong, Wisna Novera, Yiping Fan, Jakub Gruszczyk, Rajesh Chandramohanadas, Guillaume Carissimo, Matthew Zirui Tay, Lisa F. P. Ng, Jerry Kok Yen Chan, Benoit Malleret, Yves Colin, Wai-Hong Tham, Georges Snounou, Shanshan W. Howland, Julien Lescar, Ameya Sinha, François Nosten, Laurent Rénia, Ann-Marie Chacko, Abbas El Sahili, Rossarin Suwanarusk, Sebastian Maurer-Stroh, Varakorn Kosaisavee
Publikováno v:
Nature Microbiology
Nature Microbiology, 2021, 6 (8), pp.991-999. ⟨10.1038/s41564-021-00939-3⟩
Nature Microbiology, Nature Publishing Group, 2021, 6 (8), pp.991-999. ⟨10.1038/s41564-021-00939-3⟩
Nature Microbiology, 2021, 6 (8), pp.991-999. ⟨10.1038/s41564-021-00939-3⟩
Nature Microbiology, Nature Publishing Group, 2021, 6 (8), pp.991-999. ⟨10.1038/s41564-021-00939-3⟩
More than one-third of the world's population is exposed to Plasmodium vivax malaria, mainly in Asia1. P. vivax preferentially invades reticulocytes (immature red blood cells)2-4. Previous work has identified 11 parasite proteins involved in reticulo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e36a44820d86606d08b43043c9c6659
https://hal.science/hal-03448619
https://hal.science/hal-03448619
Autor:
Nicholas J. White, François Nosten
Publikováno v:
Malaria Journal, Vol 20, Iss 1, Pp 1-4 (2021)
Malaria Journal
Malaria Journal
Single Encounter Radical Cure and Prophylaxis (SERCAP) describes an ideal anti-malarial drug that cures all malaria in a single dose. This target product profile has dominated anti-malarial drug discovery and development over the past decade. The ope